HES5 and pulmonary arterial hypertension: Indeed, NOTCH3 and its downstream effector Hairy and enhancer of split 5 (HES5) were found to be overexpressed in PASMCs from PAH patients and mice exhibiting Notch3 loss-of-function mutation do not develop PH in response to chronic hypoxia [112].